Awakn Life Sciences Announces Private Placement
Toronto, Ontario–(Newsfile Corp. – April 26, 2023) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (the “Company“), a biotechnology company developing therapeutics…
Tag: Awakn Life Sciences Corp.
Awakn Life Sciences Signs Collaboration Agreement with University of Exeter for Upcoming Phase III Trial
Phase III Trial Will Assess Ketamine-Assisted Therapy for the Treatment of Severe Alcohol Use Disorder Toronto, Ontario–(Newsfile Corp. – April 18, 2023) – Awakn Life…
Awakn Life Sciences Increases Ownership of Awakn Bristol to 100% and Provides Corporate Update
Toronto, Ontario–(Newsfile Corp. – April 12, 2023) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a biotechnology company developing therapeutics to…
Awakn Life Sciences Signs Its Fourth Licensing Partnership Agreement in North America, and First in California
Partnership is Awakn’s first with a dedicated addiction treatment clinic, Ken Starr MD Wellness Group Toronto, Ontario–(Newsfile Corp. – February 28, 2023) – Awakn Life…
Awakn Life Sciences Signs Its First Licensing Partnership Agreement in Europe
Awakn Will License its Protocols for Treating Addiction and Mental Health to a Healthcare Consortium to Help Accelerate Their Development of a Chain of Clinics…